Cell surface antigens of human melanocytes and melanoma: Expression of adenosine deaminase binding protein is extinguished with melanocyte transformation

Journal of Experimental Medicine

Volumn 167, Issue 1, 1988, Pages 197-212

  Houghton, Alan N ^a   Albino, Anthony P ^a   Cordon Cardo, Carlos ^a   Davis, Laura J ^a   Eisinger, Magdalena ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; MEMBRANE ANTIGEN; RADIOISOTOPE;

CELL CULTURE; HISTOCHEMISTRY; HUMAN; MALIGNANT TRANSFORMATION; MELANOCYTE; MELANOMA; TISSUE CULTURE;

ADENOSINE DEAMINASE; ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD26; ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; CARRIER PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; CELLS, CULTURED; GENE EXPRESSION REGULATION; HARVEY MURINE SARCOMA VIRUS; HUMAN; INFANT, NEWBORN; KIRSTEN MURINE SARCOMA VIRUS; MELANOCYTES; MELANOMA; NEOPLASM PROTEINS; PRECANCEROUS CONDITIONS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023926392     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.167.1.197     Document Type: Article

References (41)

1. Clark, W. H., Jr., D. E. Elder, D. Guerry, IV, M. N. Epstein, M. H. Greene, and M. Van Horn. 1984. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum. Pathol. 15:1147.
2. National Institutes of Health Consensus Development Conference Summary. 1983. Precursors to Malignant Melanoma. 4:1-10.
3. Houghton, A. N., M. Eisinger, A. P. Albino, J. G. Cairncross, and L.J. Old. 1982. Surface antigens of melanocytes and melanoma: markers of melanocyte differentiation and melanoma subsets. J. Exp. Med. 156:1755.
4. Houghton, A. N., F. X. Real, L.J. Davis, C. Cordon-Cardo, and L.J. Old. 1987. Phenotypic heterogeneity of melanoma: relation to the differentiation program of melanoma cells. J. Exp. Med. 164:812.
5. Andy, R. J., C. L. Finstad, L. J. Old, K. O. Lloyd, and R. Kornfeld. 1984. The antigen identified by a mouse monoclonal antibody raised against human renal cancer cells is the adenosine deaminase binding protein. J. Biol. Ckem. 259:12844.
6. Carey, T. E., T. Takahashi, L. A. Resnick, H. F. Oettgen, and L.J. Old. 1967. Cell surface antigens of human malignant melanoma. I. Mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. Proc. Natl. Acad. Sci. USA. 73:3278.
7. Eisinger, M., and O. Marko. 1982. Selective proliferation of normal human melanocytes in vitro in the presence of phorbol ester and cholera toxin. Proc. Natl. Acad. Sci. USA. 79:2018.
8. Eisinger, M. E., O. Marko, S.-I. Ogata, and L. J. Old. 1985. Growth regulation of human melanocytes. Mitogenic factors in extracts of melanoma, astrocytoma, and fibroblast cell lines. Science (Wash. DC). 229:984.
9. Ueda, R., S.-I. Ogata, D. M. Morrissey, C. L. Finstad, J. Szkudlarek, W. F. Whitmore, H. F. Oettgen, K. O. Lloyd, and L. J. Old. 1981. Cell surface antigens of human renal cancer defined by mouse monoclonal antibodies, identification of tissue-specific kidney glycoproteins. Proc. Natl. Acad. Sci. USA. 78:5122.
10. Finstad, C. F., C. Cordon-Cardo, N. H. Bander, W. F. Whitmore, M. R. Melamed, and L.J. Old. 1985. Specificity analysis of mouse monoclonal antibodies defining cell surface antigens of human renal cancer. Proc. Natl. Acad. Sci. USA. 82:2955.
11. Dippold, W. G., K. O. Lloyd, L. T. C. Li, H. Ikeda, H. F. Oettgen, and L. J. Old. 1980. Cell surface antigens of human malignant melanoma. Definition of six new antigenic systems with mouse monoclonal antibodies. Proc. Natl. Acad. Sci. USA. 77:6114.
12. Houghton, A. N., H. Brooks, R.J. Cote, M. C. Taormina, H. F. Oettgen, and L.J. Old. 1983. Detection of cell surface and intracellular antigens by human monoclonal antibodies: hybrid cell lines derived from lymphocytes of patients with malignant melanoma. J. Exp. Med. 158:53.
13. Houghton, A. N., M. C. Taormino, H. Ikeda, T. Watanabe, H. F. Oettgen, and L. J. Old. 1980. Serological survey of normal humans for natural antibody to cell surface antigens of melanoma. Proc. Natl. Acad. Sci. USA. 77:4260.
14. Cordon-Cardo, C, C. L. Finstad, N. H. Bander, and M. R. Melamed. 1987. Immu-noanatomic distribution of cytostructural and tissue-associated antigens in the human urinary tract. Am. J. Pathol. 126:269.
15. Houghton, A. N., T. M. Thomson, D. Gross, H. F. Oettgen, and L.J. Old. 1984. Surface antigens of melanoma and melanocytes. Specificity of induction of la antigens by human gamma interferon. J. Exp. Med. 160:255.
16. Albino, A. P., A. N. Houghton, M. Eisinger, J. S. Lee, R. R. S. Kantor, A. I. Oliff, and L.J. Old. 1986. Class II histocompatability antigen expression in human melanocytes transformed by Harvey murine sarcoma virus (Ha-MSV) and Kirsten MSV retroviruses. J. Exp. Med. 164:1710.
17. Pincus, T., J. W. Hartley, and W. P. Rowe. 1975. A major genetic locus affecting resistance to infection with murine leukemia virus. IV. Dose-response relationships in Fv-1 sensitive and resistant cell cultures. Virology. 65:333.
18. Halaban, R., and F. D. Alfano. 1984. Selective elimination of fibroblasts from cultures of normal human melanocytes. In Vitro. 20:447.
19. Daddona, P. E., and W. N. Kelley. 1979. Human adenosine deaminase. Stoichiometry of the adenosine deaminase-binding protein complex. Biochim. Biophys. Acta. 580:302.
20. Celis, J. E., R. Bravo, P. Mose Larsen, S. J. Fey, J. Bellatin, and A. Celis. 1983. Expression of cellular proteins in normal and transformed human cultured cells and tumors. Two-dimensional gel electrophoresis as a tool to study neoplastic transformation and cancer. In Two Dimensional Gel Electrophoresis of Proteins: Methods and Applications. J. E. Celis and R. Bravo, editors. Academic Press, New York. 307-342.
21. Bishop, J. M. 1987. The molecular genetics of cancer. Science (Wash. DC). 235:305.
22. Bishop, J. M. 1983. Cellular oncogenes and retroviruses. Annu. Rev. Biochem. 52:301.
23. Balaban, G. B. M. Herlyn, W. H. Clark, Jr., and P. C. Nowell. 1986. Karyotypic evolution in human malignant melanoma. Cancer Genet. Cytogenet. 19:113.
24. Pederson, M. I., J. W. Bennett, and N. Wang. 1986. Nonrandom chromosomal structural aberrations and oncogene loci in human malignant melanoma. Cancer Genet. Cytogenet. 20:11.
25. Herlyn, M., J. Thurin, G. Balaban, J. L. Bennicelli, D. Herlyn, D. E. Elder, E. Bondi, D. Guerry, P. Nowell, W. E. Clark, and H. Koprowski. 1985. Characteristics of cultured human melanocytes isolated from different stages of tumor progression. Cancer Res. 45:5670.
26. Herlyn, M., G. Balaban, J. Bennicelli, D. Guerry, IV, R. Halaban, D. Herlyn, D. E. Elder, G. G. Maul, Z. Steplewski, P. C. Nowell, W. H. Clark, and H. Koprowski. 1985. Primary melanoma cells of the vertical growth phase: similarities to metastatic cells. J. Natl. Cancer Inst. 71:283.
27. Johnson, J. P., M. Demmer-Dieckmann, T. Meo, M. R. Hadam, and G. Riethmuller. 1981. Surface antigens of human melanoma defined by monoclonal antibodies. I. Biochemical characterizations of two antigens found on cell lines and fresh tumors of diverse origin. Eur. J. Immunol. 11:825.
28. Holzman, B., J. P.Johnson, P. Kaudewitz, and G. Riethmuller. 1985. In situ analysis of antigens on malignant and benign cells of the melanocyte lineage. Differential expression of two cell surface molecules gp75 and p89. J. Exp. Med. 161:366.
29. Lehman, J. M., B. Holzmann, E. W. Brietbart, P. Schmiegelow, G. Riethmuller, and J. P. Johnson. 1987. Discrimination between benign and malignant cells of the melanocyte lineage by two novel antigens, a glycoprotein with a molecular weight of 113,000 and a protein with a molecular weight of 76,000. Cancer Res. 47:841.
30. Brocker, E. B., L. Suter, J. Bruggen, D.J. Ruiter, E. Macher, and C. Sorg. 1985. Phenotypic dynamics in human malignant melanoma. Int. J. Cancer. 36:29.
31. Ruiter, D. J., G. M. Dingjan, P. M. Steijlen, M. van Beveren-Hooyer, C. B. Graaff-Reitsma, W. Bergmann, G. N. P. van Mujen, and S. O. Warnaar. 1985. Monoclonal antibodies selected to discriminate between malignant melanomas and nevocellular nevi.y. Invest. Dermatol. 85:4.
32. Holzman, B., E. B. Brocker.J. M. Lehmann, D.J. Ruiter, C. Sorg, G. Riethmuller, and J. P.Johnson. 1987. Tumor progression in human malignant melanoma: five stages defined by their antigenic phenotype. Int. J. Cancer. 39:466.
33. Van der Weyden, M. B., and W. N. Kelly. 1976. Human adenosine deaminase. Distribution and properties. J. Biol. Chem. 251:5448.
34. Schrader, W. P., and A. R. Stacy. 1979. Immunoassay of the adenosine deaminase complexing proteins of human tissues and body fluids. J. Biol. Chem. 254:11958.
35. Trotta, P. P., and M. E. Balis. 1978. Characterization of adenosine deaminase from normal colon and colon tumors. Evidence for tumor-specific variants. Biochemistry. 17:270.
36. Inwood, M., S. Povey, and J. D. A. Delhanty. 1980. Comparison of isozymes in fetal, adult and transformed fibroblasts. Cell Biol. Int. Rep. 4:327.
37. Herbschleb-Voogt, E., J. Ten Kate, and P. Meera Khan. 1983. Adenosine deaminase complexing protein (ADCP): a transformation sensitive protein with potentials of a cancer marker. Anticancer Res. 3:95.
38. Ten Kate, J., J. T. Wijnen, J. Boldewijn, P. M. Meera Khan, and F. T. Bosman. 1985. Immunohistochemical localization of adenosine deaminase complexing protein in intestinal mucosa and in colorectal adenocarcinoma as a marker for tumour cell heterogeneity. Histochem.J. 17:23.
39. Ten Kate, J., J. T. Wijnen, R. G. M. van der Goes, R. Quadt, G. Griffioen, F. T. Bosman, and P. Meera Khan. 1984. Quantitative changes in adenosine deaminase isozymes in human colorectal adenocarcinomas. Cancer Res. 44:4688.
40. Ten Kate, J., H. F. G. M. van den Ingh, P. Meera Khan, and F. T. Bosman. 1986. Adenosine deaminase complexing protein (ADCP) immunoreactivity in colorectal adenocarcinoma. Int. J. Cancer. 37:479.
41. Andy, R. J., and R. Kornfeld. 1982. The adenosine deaminase binding protein of human skin Fibroblasts is located on the cell surface. J. Biol. Chem. 257:7922.